Results 141 to 150 of about 54,150 (315)

Electroconvulsive Therapy and Time to Psychiatric Readmission in Schizophrenia

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction There is evidence that electroconvulsive therapy (ECT) can augment the effects of antipsychotics in schizophrenia. However, there is limited evidence from Western populations on whether ECT reduces the risk of relapse compared to non‐ECT treatment in schizophrenia.
Linnea Stenmark, Mussie Msghina, Axel Nordenskjöld   +2 more
wiley   +1 more source

Predicting the first episode of psychosis [PDF]

Nature Medicine, 2020
openaire   +2 more sources

Does the Loss of Autobiographical Memories Contribute to the Therapeutic Effect of Electroconvulsive Therapy?

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Objective For decades, a persistent claim has been that autobiographical memory loss after electroconvulsive therapy (ECT) for depression might actually contribute to ECT efficacy by reducing or even eliminating autobiographical memories. To test this claim, the primary aim of this study is to examine the association between autobiographical ...
Mike van Kessel, Joris van der Vlugt‐Molenaar, Isidoor O. Bergfeld, Eric van Exel, Jaap Murre, Jasmien Obbels, Pascal Sienaert, Kristof Vansteelandt, Esmée Verwijk   +8 more
wiley   +1 more source

A validation of a new measure of activity in psychosis

, 2006
Despite demonstrated relationships between activity and clinical change, we lack effective measures of time use in psychosis. Existing time budget measures of activity are demanding to complete, and thus unsuited to routine clinical use as measures of ...
Garety, PA, Dunn, Graham, Bebbington, P E, Freeman, D, Dunn, G., Dunn, G, Bebbington, PE, Jolley, S., Bebbington, P.E., Garety, P A; id_orcid, Ellett, L, Kuipers, E; id_orcid, Kuipers, Elizabeth, Fowler, DG, Garety, Philippa A., Fowler, G., Fowler, D G, Kuipers, E, Garety, P.A., Fowler, David G., Bebbington, Paul E., Freeman, D., Freeman, Daniel, Jolley, Suzanne, Jolley, S, Ellett, Lyn, Kuipers, E.   +26 more
core   +1 more source

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

Addiction, EarlyView.
Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted
Amandine Luquiens, Dahbia Belahda, Carine Graux, Noe Igounenc, Chris Serrand, Paul Rochefort, Thibault Mura, Felix Sergent   +7 more
wiley   +1 more source

Factors Associated with Duration of Untreated Psychosis - A Retrospective Study done in a Rural Medical College

Archives of Medicine and Health Sciences
Background and Aim: Duration of untreated psychosis (DUP) is the measure of time from the emergence of the psychosis to intervention. There is a lot of controversy about its importance and the factors affecting the length of it.
Arushi Singh, M. Poonam, S. S. Krithishree, R. Annapoorna   +3 more
doaj   +1 more source

Emotion and psychosis: Links between depression, self-esteem, negative schematic beliefs and delusions and hallucinations

, 2006
Background: The role of emotion in psychosis is being increasingly recognised. Cognitive conceptualisations of psychosis (e.g. [Garety, P.A., Kuipers, E.K., Fowler, D., Freeman, D., Bebbington, P.E., 2001.
Fowler, DG, Smith, Ben, Dunn, Graham, Smith, B, Fowler, D G, Freeman, D, Kuipers, E, Bebbington, Paul, Garety, P, Fowler, David G., Dunn, G, Bashforth, H, Garety, Philippa, Freeman, Daniel, Bebbington, P, Garety, P; id_orcid, Bashforth, Hannah, Kuipers, E; id_orcid, Kuipers, Elizabeth   +18 more
core   +1 more source

Diurnal‐Only Foslevodopa/Foscarbidopa

Movement Disorders Clinical Practice, EarlyView.
Alexandra McGuckin, Yu‐Yan Poon, Galit Kleiner, Alfonso Fasano   +3 more
wiley   +1 more source

Outdated tools, underestimated harm: Modernizing cannabis surveillance in a post‐legalization era

Addiction, EarlyView.
Abstract Background Canada's 2018 legalization of non‐medical cannabis was positioned as a public health initiative, intended to shift cannabis use from criminalization to regulation. Since then, cannabis access and consumption have grown significantly but the systems used to monitor cannabis‐related harms have not kept pace.
Anees Bahji
wiley   +1 more source

Associations of cannabis use, tobacco use and co‐use with brain volume: A systematic review and meta‐analysis

Addiction, EarlyView.
Abstract Background and aims Cannabis is the most widely used illicit drug worldwide and is often co‐used with tobacco, the leading cause of preventable death. Although cannabis and tobacco have distinct neurobiological actions, their associations with brain volumes are unclear.
Katherine Sawyer, Tom P. Freeman, Martine Skumlien, Esther Walton, Thomas Lancaster, Jorien L. Treur, Valentina Lorenzetti, Anna K. M. Blackwell, Chloe Burke, Richie J. Carr, Constantinos Constantinides, Maisie Cox, Sarah Dance, Shadi Daryan, Sorcha Hamilton, Tom Jenkins, Gemma M. J. Taylor   +16 more
wiley   +1 more source